Skip to main content

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents) was previously published as Current Medicinal Chemistry - Anti-Cancer Agents.

Publisher: Bentham Science Publishers

More about this publication?
Volume 18, Number 11, 2018

Articles

Free Content Graphical Abstracts
pp. i-vii(7)

Favourites:
ADD

Free Content Meet Our Regional Editor
pp. 1507-1507(1)
Author: Okazaki, Isao

Favourites:
ADD

Research article

Computational Study of the Binding Modes of Diverse DPN Analogues on Estrogen Receptors (ER) and the Biological Evaluation of a New Potential Antiestrogenic Ligand
pp. 1508-1520(13)
Authors: Martinez-Archundia, M.; García-Vázquez, J.B.; Colin-Astudillo, B.; Bello, M.; Prestegui-Martel, B.; Chavez-Blanco, A.; Dueñas-González, A.; Fragoso-Vázquez, M.J.; Mendieta-Wejebe, J.; Abarca-Rojano, E.; Ordaz-Rosado, D.; García-Becerra, R.; Castillo-Bautista, D.; Correa Basurto, J.

Favourites:
ADD

Determination of the Apoptotic Effect and Molecular Docking of Benzamide Derivative XT5 in K562 Cells
pp. 1521-1530(10)
Authors: Ozkan, Tulin; Hekmatshoar, Yalda; Ertan-Bolelli, Tugba; Hidayat, Andry N.; Beksac, Meral; Aki-Yalcin, Esin; Yalcin, Ismail; Sunguroglu, Asuman

Favourites:
ADD

Synthesis and Biological Evaluation of Novel Triazoles Linked 7-hydroxycoumarin as Potent Cytotoxic Agents
pp. 1531-1539(9)
Authors: Farooq, Saleem; Hussain, Aashiq; Qurishi, Mushtaq A.; Hamid, Abid; Koul, S.

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Pinocembrin-Enriched Fractions of Elytranthe parasitica (L.) Danser Modulates Apoptotic and MAPK Cellular Signaling in HepG2 Cells
pp. 1563-1572(10)
Authors: Kumar, Nimmy; Shrungeswara, Akhila H.; Mallik, Sanchari B.; Biswas, Subhankar; Mathew, Jesil; Nandakumar, Krishnadas; Mathew, Jessy; Lobo, Richard

Favourites:
ADD

Peniciketal A, A Novel Spiroketal Compound, Exerts Anticancer Effects by Inhibiting Cell Proliferation, Migration and Invasion of A549 Lung Cancer Cells
pp. 1573-1581(9)
Authors: Gao, Xue; Zhou, Yuming; Zheng, Xiaoqi; Sun, Hongliu; Zhang, Jing; Liu, Weizhong; Pan, Xiaohong

Favourites:
ADD

Bursal Hexapeptide, A Potential Immunomodulator, Inhibits Tumor Cells Proliferation via p53 Signaling Pathway
pp. 1582-1588(7)
Authors: Zhang, Cong; Zhou, Jiangfei; Li, Shengnan; Cai, Kairui; Guo, Xiangling; Liao, Chengshui; Wang, Chen

Favourites:
ADD

Novel Nicotinonitrile Derivatives Bearing Imino Moieties Enhance Apoptosis and Inhibit Tyrosine Kinase
pp. 1589-1598(10)
Authors: El-Hashash, Maher A.; El-Bordany, Eman A.; Marzouk, Magda I.; El-Naggar, Abeer M.; Nawar, Tarek M.S.; El-Sayed, Wael M.

Favourites:
ADD
Favourites:
ADD

Synthesis and Evaluation of a Series of 1,3,4-Thiadiazole Derivatives as Potential Anticancer Agents
pp. 1606-1616(11)
Authors: Altıntop, Mehlika D.; Sever, Belgin; Özdemir, Ahmet; Ilgın, Sinem; Atlı, Özlem; Turan-Zitouni, Gülhan; Kaplancıklı, Zafer A.

Favourites:
ADD

TPEN Exerts Antitumor Efficacy in Murine Mammary Adenocarcinoma Through an H2O2 Signaling Mechanism Dependent on Caspase-3
pp. 1617-1628(12)
Authors: Soto-Mercado, Viviana; Mendivil-Perez, Miguel; Urueña-Pinzon, Claudia; Fiorentino, Susana; Velez-Pardo, Carlos; Jimenez-Del-Rio, Marlene

Favourites:
ADD

Selection of a GPER1 Ligand via Ligand-based Virtual Screening Coupled to Molecular Dynamics Simulations and Its Anti-proliferative Effects on Breast Cancer Cells
pp. 1629-1638(10)
Authors: Martínez-Muñoz, Alberto; Prestegui-Martel, Berenice; Méndez-Luna, David; Fragoso-Vázquez, Manuel J.; García-Sánchez, José Rubén; Bello, Martiniano; Martínez-Archundia, Marlet; Chávez-Blanco, Alma; Dueñas-González, Alfonso; Mendoza-Lujambio, Irene; Trujillo-Ferrara, José; Correa-Basurto, José

Favourites:
ADD

Synthesis and Anticancer Activity of 9-O-Pyrazole Alkyl Substituted Berberine Derivatives
pp. 1639-1648(10)
Authors: Xiao, Daipeng; He, Fen; Peng, Dongming; Zou, Min; Peng, Junying; Liu, Pan; Liu, Yanfei; Liu, Zhenbao

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content